It has now been a week since the hugely successful Alzheimer’s Research UK Conference 2015 got underway. Hearing from clinicians who, on a daily basis, diagnose, treat, and talk with people who have dementia provided valuable context for the rest of the conference.
People with FTD typically experience changes in personality, emotions and decision making; all symptoms that can be confused for other conditions.
There is growing evidence linking vascular disease and Alzheimer’s disease, and we’ve heard this afternoon at the Alzheimer’s Research UK Conference about research that seeks to understand these links.
There has been lots of discussion, both within the popular press and the research community, about the importance of early detection and diagnosis of the diseases that cause dementia.
In several forms of dementia, including Alzheimer’s, frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy, tau starts to behave out of character.
While inflammation can protect the body, too much of a good thing can have its consequences.
Amyloid has long been a key focus of Alzheimer’s research, but as today’s session showed, scientists are still discovering more about it all the time.
The meeting is the largest dementia research conference in the UK and scientists from across our Research Network will be joined by international dementia experts; a global approach to this global medical challenge.